It has started with great success the 2014 World Congress of Asthma in Mexico

Super User Saturday, 29 March 2014 17:14

With the presence of large number of attendees from around the world and a panel of recognized experts in charge of conferences and workshops has been initiated the XXII World Congress of Asthma in Mexico City.

CME Credits World Congress of Asthma 2014

Super User Monday, 24 March 2014 21:06

European Union of Medical Specialists 
EACCME - European Accreditation Council for
Continuing Medical Education
Institution of the UEMS
Avenue de la Couronne 20, B-1050, Brussels
We are pleased to inform you that XXII World Congress of Asthma (Mexico City, Mexico, 29.03.–1.04.2014) was granted 24 European CME credits (ECMEC) by the European Accreditation Council for Continuing Medical Education (EACCME). 

You can download the Letter of Accreditation here.

Highlights of WCA 2014 Mexico City

Super User Thursday, 06 March 2014 14:48
INTERASMA in the XXI Century
INTERASMA will celebrate its 60th Anniversary during WCA 2014 in Mexico City. INTERASMA is an evolving organization and it is ready to cope with new challenges in terms of clinical practice, education, communication, and research in the field of asthma. This process started in Montecarlo, in the principality of Monaco, during WCA 2008 chaired by G. Walter Canonica and Carlos E. Baena-Cagnani and it has continued through the years, with WCA 2010 in Athens led by Ronald Dahl and the remarkable WCA 2012 in Quebec chaired by Louis-Philippe Boulet.
The new website, the new INTERASMA journal “Asthma Research and Practice”, the manifestos in collaboration with WAO, Ga2len, SLaai, etc. and other initiatives are also part of this revitalizing process.
We have wonderful reasons to celebrate INTERASMA 60th anniversary. INTERASMA would also like to thank the founders and those predecessors that have kept the Global Asthma Association alive.
Join us in this celebration!
Highlights of WCA 2014 Mexico City
During the Congress in Mexico and in consonance with INTERASMA philosophy, four keynote award lectures will take place, one per day.
In one of them, Professor Ronald Dahl will receive the Albert K. Oehling INTERASMA Award for his outstanding career in the fields of Pulmonology, Asthma and Allergy.
Prof. Albert K. Oehling was Secretary General and later President of INTERASMA and he also presided the World Congress of Asthma in Barcelona.
Through this session, INTERASMA would like to express its gratitude to these two outstanding clinicians, researchers and leaders.
Tuesday 1st April | 11:45-12:30 | Room A
KL403. Albert K. Oehling Conference
Chairs: Carlos E. Baena-Cagnani, G. Walter Canonica
Ronald Dahl, “The eosinophil granulocyte and asthma, allergy and related disorders”

World Congress of Asthma 2014 is approaching soon! Benefit from the medium registration period which soon ends

Super User Saturday, 01 March 2014 17:38

Interasma Newsletter

Super User Sunday, 23 February 2014 03:55
Interasma Newsletter
View this email in your browser

Dear colleagues and friends,
TheWorld Congress of Asthma is approaching and we are excited waiting for the days in which we'll join a superb Congress in Mexico.The Scientific Programme is amazing, with three simultaneous tracks: the pediatric one, asthma for adults, and a third one for specialists. 
Mexico is an outstanding city, full of culture and with the superb Mexican hospitality.
I kindly invite all of you to join us to enjoy this cutting edge programme in a friendly working atmosphere under the motto "Translating science into clinical practice: how to improve asthma management in 2014"
Warm regards,
Carlos E. Baena-Cagnani
President of INTERASMA
Queridos colegas y amigos,
Se acerca el Congreso Mundial de Asma y estamos esperando que llegue el día para compartir un congreso estupendo  en México.
El programa científico es excepcional, con tres senderos simultáneos: uno pediátrico, otro de asma para adultos y un tercero para especialistas.
México es una ciudad fabulosa, llena de cultura y con la proverbial hospitalidad mexicana. Los invito a todos a disfrutar de este innovador programa en un ambiente de fraternal trabajo bajo el lema Aplicando la ciencia en la práctica clínica diaria: Cómo optimizar el manejo del asma en 2014".
Con cálido afecto,
Carlos E. Baena-Cagnani
President of INTERASMA

Please visit 
XXII World Congress of Asthma
WCA 2014 Mexico City INTERASMA
INTERASMA is the Asthma Global Association and fosters international collaboration.
INTERASMA wants to sincerely thank the international organizations that are also participating in the development of the scientific programme:

View the Scientific Programme Online
CA 2014 web site

World Congress of Asthma 2014 - Scientific Programme

Super User Thursday, 20 February 2014 18:37
Preliminary Programme


Interasma website

Content Manager Monday, 03 February 2014 12:11

After 10 years of growth and permanence in our old website, Interasma has created a new website accessing new technologies, with full integration to social media to provide more and better information to our members and to the medical community and patients interested in bronchial asthma globally.
Enjoy our renovated web site and new sections:

WCA 2014 - Program at a Glance

Juan Carlos Ivancevich Monday, 13 January 2014 15:35

The WCA-2014 Program at a Glance will be updated in due course. Please check back.

Saturday March 29
  Sunday March 30   Monday March 31   Tuesday April 1
    Morning Sessions   Morning Sessions   Morning Sessions
Morning Sessions   Morning Sessions   Morning Sessions   Morning Sessions
Break   Break   Break   Break
Key Note Lecture   Key Note Lecture   Key Note Lecture   Key Note Lecture
Lunch Symposia   Lunch Symposia   Lunch Symposia   Lunch Symposia
Plenary Session   Plenary Session   Plenary Session   Plenary Session
Break   Break   Break   Break
Afternoon Sessions   Afternoon Sessions   Afternoon Sessions   Afternoon Sessions
Opening Ceremony   Afternoon Sessions   Afternoon Sessions   Closing Ceremony
    Cultural Event   President's Dinner    


WCA 2014 - Scientific Board & Scientific Program Committee

Juan Carlos Ivancevich Wednesday, 08 January 2014 15:35
Scientific Advisory Board
Jean Bousquet, France
Andrea Rossi, Italy
Gustavo Rodrigo, Uruguay
Stephen T. Holgate, UK
Pediatric Advisory Board
Andy Bush, UK
Stanley Szefler, USA
Giovanni Rossi, Italy
Peter Le Souëf, Australia
Dirceu Solé, Brazil
Hugo Van Bever, Singapore
Karin Lødrup Carlsen, Norway
Adnan Čustović, UK.
Scientific Programme Committee
Carlos E. Baena-Cagnani, Argentina - G. Walter Canonica, Italy
Louis-Philippe Boulet, Canada - Lawrence DuBuske, USA
Mark FitzGerald, Canada
Gennaro D'Amato, Italy
Juan A. Mazzei, Argentina
Ruby Pawankar, Japan.
J. Christian Virchow, Germany
Interasma Project Leader
Niki Gargassoula, Greece email address: This email address is being protected from spambots. You need JavaScript enabled to view it.

WCA 2014 -Main Topics

Juan Carlos Ivancevich Tuesday, 07 January 2014 15:35
Track I: 
Adult: Knowledge Translating
.     Track II: 
Asthma Knowledge Translating
.     Track III: 
Paediatric Programme
  • Asthma: a disease of many phenotypes
  • Asthma in the elderly
  • Occupational asthma
  • Asthma and obesity: what is the relationship?
  • Biomarkers of treatment responses
  • Links between astma and rhinitis
  • Upper airway influences on lower airways
  • Basic principles of guidelines implementation
  • Translation of GINA strategy into care
  • How to address care gaps in primary care
  • Emergency approach to asthma attacks in adults
  • Management of asthma in pregnancy
  • Adherence to Treatment in Allergy, Asthma & COPD: a neglected issue.
  • COPD Treatments as future Asthma Treatment
  • Fixed airflow obstruction in Asthma: pathological basis and consequences for treatment
  • Inhaled corticosteroids: different mechanisms and efficacy in Asthma and COPD
  • LAMA in Asthma: only for patients with severe poorly reversible airflow obstruction?
  • Triple therapy (ICS + LABA + LAMA) popular in COPD but forbidden in Asthma?
  • Tobacco in asthma and rhinitis
  • Knowledge Translation in Health Care: from evidence to practice


  • Monoclonal antibodies
  • New COPD Treatments
  • PROTEOMICS: a step forward in understanding Asthma
  • Severe Asthma: a different phenotype or different phenotypes?
  • Genetic factors and epigenetics
  • How does epithelial integrity protect against environmental insults
  • Breakdown in epithelial protection in Rhinosinusitis
  • Role of component resolved diagnostics
  • Subphenotyping and endotyping asthma
  • Diagnostic genetic scores in personalising diagnoses of allergy and asthma
  • Pharmacogenetics in deciding treatment options
  • Biodiversity and allergic disease
  • What is climate change doing to our environment in relation to allergy trends?
  • The changing microbiome and allergy
  • Smoking Cessation – Essential part of asthma treatment
  • The role of infection in asthma exacerbations
  • New biologic agents for treating severe asthma
  • A Novel paradigm for generating relevant evidence for guidelines: real life trials
  • Clusters and biomarkers of severe asthma in adults
  • Allergens in acute asthma exacerbations


  • Chronic rhinosinusitis and asthma in childhood. How to deal with it?
  • Prenatal and early life gene/ environmental programming
  • Predictive risk of rhinitis for asthma in children
  • Allergic and non allergic rhinitis in children under 5: implications for care
  • Severe Paediatric asthma
  • Risk factors for wheezing/asthma in infants
  • Asthma and obesity: association or epiphenomenon
  • Pulmonary function in infants and its contribution for the diagnosis of asthma
  • Allergens and/or virus and/or allergens in the development of asthma: the chicken or the egg dilemma
  • Managing severe asthma in childhood
  • Lung function decline: when does it start?
  • Are COPD starting in infants?
  • The MEDALL project: mechanisms of allergy
  • PAPA: Prevention of Allergy, Prevention of Asthma
  • Measuring lung function in children
  • Inflammatory markers of asthma and children
  • Genome-wide association influencing allergic sensitization
  • The aerosol therapy and lung deposition in children
  • What is the role of bacteria in airway inflammation and wheezing?

Interasma on Twitter

Interasma RT @Aller_MD: Weekly Clinical Case Challenge from Derm101. What is your diagnosis?
Interasma RT @Aller_MD: Top story: WORLD ALLERGY CONGRESS | WAC2019 - WORLD ALLERGY CONGRESS, see more
Interasma RT @Aller_MD: “Global Temperature Affects Dengue”
Interasma RT @Aller_MD: “The Risks and Benefits of Expedited Drug Reviews. The US Food and Drug Administration (FDA) oversees several programs that e…
Interasma RT @Aller_MD: “Health Data and Privacy in the Digital Era”

Editor: Juan C. Ivancevich, MD

Copyright © Interasma 2003-2017  •  Terms of Use  •  Privacy Policy  •  Contact Us  •  Sitemap

Powered by FREI SA